Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

被引:1125
作者
Darrah, Patricia A.
Patel, Dipti T.
De Luca, Paula M.
Lindsay, Ross W. B.
Davey, Dylan F.
Flynn, Barbara J.
Hoff, Soren T.
Andersen, Peter
Reed, Steven G.
Morris, Sheldon L.
Roederer, Mario
Seder, Robert A.
机构
[1] NIAID, Cellular Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen S, Denmark
[3] Infect Dis Res Inst, Seattle, WA 98104 USA
[4] US FDA, Ctr Biol Evaluat & Res, Lab Mycobacterial Dis & Cellular Immunol, Bethesda, MD 20892 USA
[5] NIAID, Vaccine Res Ctr, ImmunoTechnol Sect, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1038/nm1592
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD4(+) T cells have a crucial role in mediating protection against a variety of pathogens through production of specific cytokines. However, substantial heterogeneity in CD4(+) T-cell cytokine responses has limited the ability to define an immune correlate of protection after vaccination. Here, using multiparameter flow cytometry to assess the immune responses after immunization, we show that the degree of protection against Leishmania major infection in mice is predicted by the frequency of CD4(+) T cells simultaneously producing interferon-gamma, interleukin-2 and tumor necrosis factor. Notably, multifunctional effector cells generated by all vaccines tested are unique in their capacity to produce high amounts of interferon-gamma. These data show that the quality of a CD4(+) T-cell cytokine response can be a crucial determinant in whether a vaccine is protective, and may provide a new and useful prospective immune correlate of protection for vaccines based on T-helper type 1 (T(H)1) cells.
引用
收藏
页码:843 / 850
页数:8
相关论文
共 49 条
  • [11] DISSEMINATED TUBERCULOSIS IN INTERFERON-GAMMA GENE-DISRUPTED MICE
    COOPER, AM
    DALTON, DK
    STEWART, TA
    GRIFFIN, JP
    RUSSELL, DG
    ORME, IM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2243 - 2247
  • [12] PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis
    Elias, D
    Akuffo, H
    Britton, S
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2005, 99 (05) : 363 - 368
  • [13] AN ESSENTIAL ROLE FOR INTERFERON-GAMMA IN RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION
    FLYNN, JL
    CHAN, J
    TRIEBOLD, KJ
    DALTON, DK
    STEWART, TA
    BLOOM, BR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2249 - 2254
  • [14] Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection
    Gicheru, MM
    Olobo, JO
    Anjili, CO
    Orago, AS
    Modabber, F
    Scott, P
    [J]. INFECTION AND IMMUNITY, 2001, 69 (01) : 245 - 251
  • [15] Antigen challenge leads to in vivo activation and elimination of highly polarized TH1 memory T cells
    Hayashi, N
    Liu, DC
    Min, BK
    Ben-Sasson, SZ
    Paul, WE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (09) : 6187 - 6191
  • [16] Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042
  • [17] Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation
    Jelley-Gibbs, DM
    Brown, DM
    Dibble, JP
    Haynes, L
    Eaton, SM
    Swain, SL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (05) : 697 - 706
  • [18] Repeated stimulation of CD4 effector T cells can limit their protective function
    Jelley-Gibbs, DM
    Dibble, JP
    Filipson, S
    Haynes, L
    Kemp, RA
    Swain, SL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (07) : 1101 - 1112
  • [19] Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-γ generation
    Leal, IS
    Smedegård, B
    Andersen, P
    Appelberg, R
    [J]. IMMUNOLOGY, 2001, 104 (02) : 157 - 161
  • [20] The duration of antigenic stimulation determines the fate of naive and effector T cells
    Lezzi, G
    Karjalainen, K
    Lanzavecchia, A
    [J]. IMMUNITY, 1998, 8 (01) : 89 - 95